Costello Asset Management’s Gilead Sciences GILD Stock Holding History

Costello Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66.3K	Sell	525 -200	-28%	-$26.4K	0.02%	216
2026 Q1	$101K	Buy	725 +300	+71%	+$42K	0.03%	166
2025 Q4	$52.2K	Buy	425 +25	+6%	+$3.04K	0.02%	218
2025 Q3	$44.4K	Buy	400 +80	+25%	+$9.09K	0.01%	256
2025 Q2	$35.5K	Buy	320 +227	+244%	+$24.2K	0.01%	285
2025 Q1	$10.4K	Buy	+93	New	+$9.6K	﹤0.01%	450
2021 Q4	–	Sell	-125	Closed	-$9K	–	242
2021 Q3	$9K	Sell	125 -25	-17%	-$1.76K	0.01%	177
2021 Q2	$10K	Hold	150	–	–	0.01%	177
2021 Q1	$10K	Hold	150	–	–	0.01%	193
2020 Q4	$9K	Hold	150	–	–	0.01%	183
2020 Q3	$9K	Buy	+150	New	+$10.4K	0.01%	166

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Costello Asset Management's GILD Position: Q2 2026 in Review

Costello Asset Management reduced its Gilead Sciences (GILD) stake by 28% in Q2 2026, selling an estimated $26.4K and leaving 525 shares worth $66.3K. The position accounts for 0.02% of the portfolio, ranked #216.

Costello Asset Management first reported a position in GILD in Q3 2020 and has held it in 11 quarters since. The position peaked at $101K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Costello Asset Management held 525 shares of Gilead Sciences worth $66.3K as of Q2 2026.
Costello Asset Management sold 200 Gilead Sciences shares in Q2 2026, an estimated $26.4K.
Gilead Sciences made up 0.02% of Costello Asset Management's portfolio in Q2 2026, its #216 holding.
Costello Asset Management first reported a position in Gilead Sciences in Q3 2020 and has held it in 11 quarters since.
Costello Asset Management's Gilead Sciences position peaked at $101K in Q1 2026.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Costello Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.